Has such an impact on disease and in addition the issue of ecigarettes where we do not know what either the short term or the longterm impact is from the cigarettes themselves, nor do we know what the implications are for behavior. And, therefore, the nih in conjunction with the fda is conducting research to investigate these critically important areas. Thank you very much. Thank you, senator. Senator cassidy. Thank you all so much. As a practicing physician sometimes still i am so aware of yalls good work and i think we should double your budget because i understand the impact that would have upon my patients. Among which when i did my residency in 1983 in los angeles the epi center of hiv, im very aware what was formally a death sentence is now something you live with. Let me ask because dr. Collins i have been concerned that 20 years ago gia that nih rebalance its hiv spending from the 10 to diseases such as alzheimers dementia which are more important now. If you receive the 7 incr
Just for the record, dr. Collins, you may have mentioned it but i dont know if i heard it the 4 target areas in hivaids, when did you announce that . That was a recent announcement . Recent evaluation of where you are headed and recent announcement . Dr. Collins it was in august. I can quickly say those 4 priorities reducing the incidents of hivaids and Research Toward a cure who are under lifelong treatment. Next generation of therapies with fewer side effects and these hivassociated comorbidities with thousands of people infected who are having some of those comorbidities and we need to understand them better. Sen. Blunt thank you. Senator capito. Sen. Capito i thank all of you on the panel. I would like to thank dr. Lorsch for spending time in West Virginia at West Virginia university, talking about a program i learned so much about, the idea program just which is a smart and successful program. I thank you for that. There is research with stroke and brain and a collaborative effort
Leveraging data from 1715 children in the MAL-ED birth cohort study, Stephanie A Brennhofer and colleagues model the expected reduction in diarrhea episodes, antibiotic use, and bystander pathogen exposure to antibiotics through the administration of Shigella vaccines.
Monthly IPTp with dihydroartemisinin–piperaquine did not improve pregnancy outcomes,
and the addition of a single course of azithromycin did not enhance the effect of
monthly IPTp with dihydroartemisinin–piperaquine. Trials that combine sulfadoxine–pyrimethamine
and dihydroartemisinin–piperaquine for IPTp should be considered.